LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host
LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host
EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN) and
Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLEANS, June 9, 2025
Climate capitalism won’t save us Channel
… drive up demand for American agricultural products. MANILA, Philippines – The
IHG Hotels & Resorts (IHG), one of the world’s leading hotel companies, has accelerated its growth in Vietnam by signing
As Frank Lloyd Wright’s birthday on the 8th of June approaches, Illinois is stepping into the spotlight as the premier
New research from Travelzoo — the club for travel enthusiasts that reaches 30 million travellers with outstanding travel, entertainment and
Escape the extreme heat this summer and immerse yourself in the authentic beauty of the Algarve by visiting lesser known